- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg med Programmeret celledød-1 (PD1, PD-1)
I alt 463 resultater
-
Merck Sharp & Dohme LLCRekrutteringIkke-småcellet lungekræft | Faste tumorer | Programmeret celledød-1 (PD1, PD-1) | Programmeret celledød 1 Ligand 1 (PDL1, PD-L1) | Programmeret celledød 1 ligand 2 (PDL2, PD-L2)Japan
-
Guohui LiRekrutteringPD-1 | Immunrelaterede bivirkningerKina
-
Ningbo Cancer HospitalUkendtAvancerede maligniteter | PD-1 antistof | CAR-T cellerKina
-
Shanghai International Medical CenterUkendtAvanceret solid tumor | PD-1 antistof | CAR-T cellerKina
-
Peking UniversityIkke rekrutterer endnuGastroøsofageal Junction Cancer | Kemoradioterapi | PD-1
-
University Hospital, MontpellierAfsluttetPatienter, der modtager anti-PD-1 eller Anti-PD-L1 immunterapierFrankrig
-
Agenus Inc.AfsluttetAvancerede solide kræftformer | Advanced Solid Cancers Refractory to PD-1Forenede Stater
-
Beijing Friendship HospitalIkke rekrutterer endnu
-
Sun Yat-sen UniversityRekrutteringPD-1 inhibitor | G-CSFKina
-
Shandong New Time Pharmaceutical Co., LTDIkke rekrutterer endnu
-
Baodong QinUkendtKemoterapi effekt | Immunterapi | Tumormutationsbyrde | PD-1/L1-hæmmerKina
-
Icahn School of Medicine at Mount SinaiRekrutteringKræft | Skjoldbruskkirtel | PD-1Forenede Stater
-
Wuhan Union Hospital, ChinaRekrutteringGastroøsofageal Junction Cancer | PD-1 | Neoadjuverende kemoradioterapiKina
-
Xijing HospitalRekrutteringPD-1 | Lokalt avanceret gastrisk adenocarcinomKina
-
China Medical University, ChinaIkke rekrutterer endnuPD-1 antistof | Gastrointestinale tumorer | DC-celle | NK-celle
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; National Cancer Institute (NCI)RekrutteringRefraktær MSI - H faste tumorer forud for PD-(L) 1-terapi | MSI-H tumorerForenede Stater
-
Beijing Friendship HospitalIkke rekrutterer endnu
-
Sun Yat-sen UniversityRekrutteringPD-1 inhibitor | Granulocytkoloni-stimulerende faktorKina
-
Ascletis Pharmaceuticals Co., Ltd.RekrutteringHIV-infektioner | HIV-1-infektion | PD-L1 genmutationKina
-
Sichuan Cancer Hospital and Research InstituteIkke rekrutterer endnuIntrahepatisk cholangiocarcinom | Apatinib | PD-1 antistof | Transarteriel kemoemboliseringKina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Affiliated Cancer Hospital... og andre samarbejdspartnereRekrutteringStrålebehandling | HNSCC | PD-1Kina
-
University Hospital HeidelbergDepartment of Dermatology, Heidelberg University HospitalAfsluttetMelanom | Dyrke motion | PD-1 antistofferTyskland
-
Ascendis Pharma Oncology Division A/SRekrutteringAvanceret solid tumor | Metastatisk fast tumor | Platin-resistent kræft i æggestokkene | Lokalt avanceret solid tumor | Post Anti-PD-1 melanom | 2L+ livmoderhalskræft | Neoadjuverende melanom | Neoadjuverende ikke-småcellet lungekræft | Post Anti-PD-(L)1 ikke-småcellet lungekræft | Post Anti-PD-(L)1 småcellet...Forenede Stater, Australien, Korea, Republikken
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRekruttering
-
Shanghai Zhongshan HospitalAktiv, ikke rekrutterendeGaldevejskræft | PD-1 antistof | Lenvatinib | GemoxKina
-
Beijing Friendship HospitalAfsluttetGaldevejskræft | Capecitabin | Målrettet molekylær terapi | Anti-PD-1 terapiKina
-
Sichuan UniversityRekrutteringNSCLC | PD-1 inhibitor | Leptomeningeal metastase | Lavdosis strålebehandlingKina
-
Xuanwu Hospital, BeijingUkendtIkke-småcellet lungekræft | PD-1 antistof | Lungekræft fase II
-
Chinese PLA General HospitalRekrutteringHodgkin lymfom | Anti-PD-1 antistof resistentKina
-
Sun Yat-sen UniversityRekrutteringImmunterapi | DMMR tyktarmskræft | Anti PD-1Kina
-
Jiangsu HengRui Medicine Co., Ltd.Aktiv, ikke rekrutterendeKemoterapi effekt | Lungekræft fase IV | PD-1 antistof | Lungekræft pladecelleKina
-
Fudan UniversityIkke rekrutterer endnuMavekræft | MSI-H | Adjuverende terapi | PD-1 immunterapiKina
-
RenJi HospitalRekrutteringUrothelial carcinom blære | PD-1 inhibitorKina
-
The Affiliated Hospital of Qingdao UniversityUkendtNSCLC trin IV | PD-1 | ARID1AKina
-
Sichuan UniversityRekrutteringNSCLC | PD-1 inhibitor | Stereotaktisk kropsstrålebehandling | Lavdosis strålebehandlingKina
-
Shanghai Jiao Tong University School of MedicineRekrutteringKemoterapi | Oralt planocellulært karcinom | Anti-PD-1 | Neoadjvant terapiKina
-
Xiaorong DongUkendt
-
Shanghai Ninth People's Hospital Affiliated to...Ikke rekrutterer endnu
-
First People's Hospital of HangzhouHangzhou Cancer HospitalRekrutteringStereotaktisk kropsstrålingsterapi; PD-1 inhibitor; hypertermi; NSCLCKina
-
Chinese PLA General HospitalIkke rekrutterer endnuPD-1-hæmmer svigtede patienter med klassisk Hodgkin-lymfom
-
Diwakar DavarMerck Sharp & Dohme LLC; Gateway for Cancer ResearchIkke rekrutterer endnuPD-1 Refractory Advanced MelanomForenede Stater
-
Fudan UniversityRekrutteringCarcinosarkom | Sarcomatoid karcinom | PD-1 immunterapi | VEGFR-TKIKina
-
Fuzhou General HospitalUkendtSmåcellet lungekræft | Lunge-neoplasma | PD-1 hæmmereKina
-
Shandong New Time Pharmaceutical Co., LTDIkke rekrutterer endnuNSCLC | Ikke-småcellet lungekræft | PD-1Kina
-
Second Affiliated Hospital, School of Medicine,...RekrutteringHalspulsåreplak | Pd-1 hæmmereKina
-
Peking Union Medical College HospitalRekrutteringHepatocellulært karcinom | PD-1 inhibitor | RegorafenibKina
-
The First Hospital of Jilin UniversityAktiv, ikke rekrutterendeLokalt avanceret endetarmskræft | PD-1 | Total Neoadjuverende behandling | TislelizumabKina
-
Nanfang Hospital of Southern Medical UniversityRekrutteringEsophageal pladecellekarcinom | PD-1 inhibitorKina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityFirst Affiliated Hospital of Jinan University; Shenzhen University General...RekrutteringKarcinom | Neoplasmer i fordøjelsessystemet | Intrahepatisk cholangiocarcinom | Førstelinjes behandling | PD-1 inhibitorKina